Cargando…

Rational Pharmacological Approaches for Cognitive Dysfunction and Depression in Parkinson’s Disease

Parkinson’s disease (PD) is not a single entity but rather a heterogeneous neurodegenerative disorder. The present study aims to conduct a critical systematic review of the literature to describe the main pharmacological strategies to treat cognitive dysfunction and major depressive disorder in PD p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sandoval-Rincón, Maritza, Sáenz-Farret, Michel, Miguel-Puga, Adán, Micheli, Federico, Arias-Carrión, Oscar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379942/ https://www.ncbi.nlm.nih.gov/pubmed/25873910 http://dx.doi.org/10.3389/fneur.2015.00071

Ejemplares similares

Therapeutic Interventions for Vascular Parkinsonism: A Systematic Review and Meta-analysis
por: Miguel-Puga, Adán, et al.
Publicado: (2017)

Continuous Theta Burst Stimulation Over the Right Orbitofrontal Cortex Impairs Conscious Olfactory Perception
por: Villafuerte, Gabriel, et al.
Publicado: (2019)

Sleep Deprivation and Oxidative Stress in Animal Models: A Systematic Review
por: Villafuerte, Gabriel, et al.
Publicado: (2015)

TNR Gene Mutation in Familial Parkinson’s Disease: Possible Implications for Essential Tremor
por: Sáenz-Farret, Michel, et al.
Publicado: (2021)

Basic mechanisms of rTMS: Implications in Parkinson's disease
por: Arias-Carrión, Oscar
Publicado: (2008)

Implications of DNA Methylation in Parkinson’s Disease
por: Miranda-Morales, Ernesto, et al.
Publicado: (2017)

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

The Spectrum of Acute Disseminated Encephalomyelitis and Mild Encephalopathy with Reversible Splenial Lesion
por: Sáenz-Farret, Michel, et al.
Publicado: (2019)

Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico
por: León-García, Rodrigo, et al.
Publicado: (2023)

The Association of Olfactory Dysfunction With Depression, Cognition, and Disease Severity in Parkinson's Disease
por: Fang, Ting-Chun, et al.
Publicado: (2021)

Rationalizing Secondary Pharmacology Screening Using Human Genetic and Pharmacological Evidence
por: Deaton, Aimee M, et al.
Publicado: (2019)

Sex therapy for female sexual dysfunction
por: Pereira, Valeska Martinho, et al.
Publicado: (2013)

Magnetic Resonance Techniques Applied to the Diagnosis and Treatment of Parkinson’s Disease
por: de Celis Alonso, Benito, et al.
Publicado: (2015)

Identification of targets for rational pharmacological therapy in childhood craniopharyngioma
por: Gump, Jacob M., et al.
Publicado: (2015)

Pharmacology, Toxicology, and Rational Application of Cinnabar, Realgar, and Their Formulations
por: Guan, Huifang, et al.
Publicado: (2022)

NEUROLOGICAL SOFT SIGNS, COGNITIVE DYSFUNCTION AND VENTRICULAR BRAIN RATION IN SCHIZOPHRENICS
por: Lal, Narottam, et al.
Publicado: (1998)

Convivir con la enfermedad de Parkinson /
por: Micheli, Federico E.
Publicado: (2004)

Rational Design of Multifunctional Ferulic Acid Derivatives Aimed for Alzheimer’s and Parkinson’s Diseases
por: Guzmán-López, Eduardo Gabriel, et al.
Publicado: (2023)

Gender Was Associated with Depression but Not with Gastrointestinal Dysfunction in Patients with Parkinson's Disease
por: Xiao-ling, Qin, et al.
Publicado: (2021)

rs3764435 Associated With Parkinson's Disease in Mexican Mestizos: Case-Control Study Reveals Protective Effects Against Disease Development and Cognitive Impairment
por: Salas-Leal, Alma C., et al.
Publicado: (2019)

Brain-Computer Interface Coupled to a Robotic Hand Orthosis for Stroke Patients’ Neurorehabilitation: A Crossover Feasibility Study
por: Cantillo-Negrete, Jessica, et al.
Publicado: (2021)

COGNITIVE DYSFUNCTION IN DEPRESSION
por: John, Sajiv, et al.
Publicado: (1992)

COGNITIVE DYSFUNCTION IN DEPRESSION
por: Sharma, I., et al.
Publicado: (1984)

Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies
por: Ali, Syed A., et al.
Publicado: (2016)

Heterocyclic Compounds: Pharmacology of Pyrazole Analogs From Rational Structural Considerations
por: Costa, Rafael Fernades, et al.
Publicado: (2021)

Orthodontic camouflage of skeletal Class III malocclusion with miniplate: a case report
por: Farret, Marcel Marchiori, et al.
Publicado: (2016)

Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin
por: García-Puga, Mikel, et al.
Publicado: (2020)

Pharmacological treatment of Parkinson’s disease
por: Arabia, G
Publicado: (2010)

STRESS, DEPRESSION, AND COGNITIVE FUNCTION IN ADRD FAMILY CAREGIVERS
por: Puga, Frank, et al.
Publicado: (2019)

Toxoplasma gondii exposure and Parkinson's disease: a case–control study
por: Alvarado-Esquivel, Cosme, et al.
Publicado: (2017)

Differences in MTHFR and LRRK2 variant’s association with sporadic Parkinson’s disease in Mexican Mestizos correlated to Native American ancestry
por: Romero-Gutiérrez, Elizabeth, et al.
Publicado: (2021)

Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease
por: Taximaimaiti, Reyisha, et al.
Publicado: (2021)

Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug
por: Lee, Hee Sook, et al.
Publicado: (2012)

Evaluation of impact of teaching clinical pharmacology and rational therapeutics to medical undergraduates and interns
por: Desai, Mira K, et al.
Publicado: (2016)

Towards a rational design of solid drug nanoparticles with optimised pharmacological properties
por: Siccardi, Marco, et al.
Publicado: (2016)

Auditory- and Vestibular-Evoked Potentials Correlate with Motor and Non-Motor Features of Parkinson’s Disease
por: Shalash, Ali Soliman, et al.
Publicado: (2017)

Cognitive Deficits in Parkinson's Disease Are Associated with Neuronal Dysfunction and Not White Matter Lesions
por: Schröter, Nils, et al.
Publicado: (2023)

Cognitive dysfunction in non-demented patients with Parkinson's disease
por: Zalonis, Ioannis, et al.
Publicado: (2010)

The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease
por: Vazey, Elena M., et al.
Publicado: (2012)

Precuneus Dysfunction in Parkinson’s Disease With Mild Cognitive Impairment
por: Jia, Xiuqin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_al4g4ujp8ah345cggo8vfhmg0e